Drawing for EVGEN

USPTO serial 79330845

EVGEN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MASON, JARED MICHAEL
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EVGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SEAN P. RITCHIE

SEAN P. RITCHIE SAUL EWING LLP1500 MARKET STREET38TH FLOORPHILADELPHIA, PA 19102-2186

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of cancer, central nervous system, and inflammatory diseases; medicated preparations for use as additives to foods for human consumption, namely, sulforaphane for medical purposes; medicated preparations for use as additives to drinks for human consumption, namely, sulforaphane for medical purposes; healthcare products, namely, medication and medicinal supplements for use in the treatment of cancer, central nervous system, and inflammatory diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 26, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 7, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 5, 2023MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Oct 5, 2023ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 5, 2023OP.TOPPOSITION TERMINATED NO. 999999—
Oct 5, 2023OP.SOPPOSITION SUSTAINED NO. 999999—
Jul 3, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 19, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 14, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 1, 2023RFNPREFUSAL PROCESSED BY IB—
Apr 21, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 6, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 5, 2023OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Apr 5, 2023OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Apr 4, 2023OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Mar 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 30, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 23, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 29, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 29, 2022RFRRREFUSAL PROCESSED BY MPU—
Jul 2, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 1, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2022DOCKASSIGNED TO EXAMINER—
Jan 18, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 14, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance